TPG Closes Transfusion Therapies Deal

Texas Pacific Group has completed its $450 million acquisition of the Transfusion Therapies business of Baxter International Inc. (NYSE: BAX). Maverick Capital also participated alongside TPG. The Transfusion Therapies business includes a global product portfolio of manual and automated blood-collection products and storage equipment, as well as five manufacturing facilities located in Haina, Dominican Republic; La Chatre, France; Maricao and San German, Puerto Rico; and Nabeul, Tunisia.